SKI Market

Indian Indices

Sensex

84,031.69 648.98
( 0.78%)

Global Indices

Nasdaq

49,457.25 286.61
(0.58%)

Dow Jones

6,963.84 16.24
(0.23%)

Hang Seng

53,810.56 -530.67
(-0.98%)

Nikkei 225

10,240.27 55.92
(0.55%)

Forex

USD-INR

90.25 0.00
(0.00%)

EUR-INR

105.11 -0.09
(-0.08%)

GBP-INR

121.30 -0.13
(-0.11%)

JPY-INR

0.57 0.00
(0.08%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Strides Pharma Science Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

532531

INE939A01011

344.5797109

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

STAR

113.21

8661.01

EPS(TTM)

Face Value()

Div & Yield %

8.3

0.43

Back

hemo organic ltd

Avadh Sugar & Energy reports standalone net loss of Rs 6.59 crore in the September 2025 quarter

Nov 11,2025

Net loss of Avadh Sugar & Energy reported to Rs 6.59 crore in the quarter ended September 2025 as against net profit of Rs 0.83 crore during the previous quarter ended September 2024. Sales rose 5.72% to Rs 668.15 crore in the quarter ended September 2025 as against Rs 632.02 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	668.15	632.02	6
OPM %	2.68	5.32	-
PBDT	4.12	16.10	-74
PBT	-10.82	1.68	PL
NP	-6.59	0.83	PL

84,031.69 648.98 ( 0.78%)

49,457.25 286.61 (0.58%)

6,963.84 16.24 (0.23%)

53,810.56 -530.67 (-0.98%)

10,240.27 55.92 (0.55%)

90.25 0.00 (0.00%)

105.11 -0.09 (-0.08%)

121.30 -0.13 (-0.11%)

0.57 0.00 (0.08%)